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Abstract
Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine
disorders among women.
Objective: The aim of this study was to investigate the therapeutic effect of
hydroalcoholic extract of Nigella sativa (N. sativa) seed as a plant, the consumption of
which has been recommended in Islam, on dehydroepiandrosterone (DHEA)-induced
PCOS rats.
Materials and Methods: This experimental study was carried out on 36 Wistar female
rats (3 wk, 60 ± 10 gr). Then rats were divided into 6 groups (n = 6/each): control; PCOS-
induced (DHEA 60 mg/kg/sc); PCOS+ Metformine (30 mg/kg); and three experimental
groups receiving DHEA + hydroalcoholic extract of N. sativa seeds in doses of 50, 100
and 200 mg/kg, respectively. Blood samples were taken for the evaluation of sexual
hormones, oxidative stress, glucose, and insulin after 30 days of treatment. Ovarian
tissue was used for histopathological study.
Results: The serum levels of luteinizing hormone, testosterone, glucose, insulin
resistance, malondialdehyde, and insulin (p ≤ 0.001) and estrogen increased while
the levels of progesterone (p = 0.01) and antioxidant enzymes in the PCOS group
decreased (p ≤ 0.001).
Conclusion: The administration of the N. sativa extract to the PCOS rats resulted in
remarkable changes in the serumic factors relative to the PCOS group. In addition,
the extract improved the structure of the ovarian tissue in the PCOS rat. The
histopathological results which are in accordance with biochemical findings imply that
N. sativa seed could be useful in the treatment of PCOS, the higher doses of the extract
being more effective.
Key words: Nigella sativa seed, Oxidative stress, Insulin resistance, Polycystic ovary
syndrome, Rat.
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1. Introduction
Polycystic ovary syndrome (PCOS) is one of the
most common endocrine disorders among women
(1). The causes of PCOS can be attributed to defects
in the hypothalamic-pituitary function and insulin
action (2).
Increased androgens and obesity, insulin
resistance, and type 2 diabetes, and oxidative
stress are the long-term consequences of this
syndrome (3, 4). Disturbance in antioxidant
systems may lead to pathological outcomes such
as PCOS and disruption of the synthesis of ovarian
steroids in women (5). An impaired release of
gonadotropin associated with enhanced secretion
of luteinizing hormone (LH) compared to the
follicle-stimulating hormone (FSH) are observed
in these patients (6). Several medical treatments
are available for PCOS, however, most of them
are temporary and not definitive treatment. Given
the side effects of these drugs, identifying and
providing alternative drugs are very important (7).
In this study, the effects of Nigella sativa seeds
(N. sativa also known as black cumin) used in
traditional medicine have been investigated.
The seeds of this plant have antimicrobial
and antifungal properties, in addition to being
menstrual regulators and milk boosters (8), and
are used in Iranian traditional medicine for treating
several inflammatory and painful disorders (9).
The compounds isolated from N. sativa,
including thymoquinone, t-anethole, carvacrol,
and 4-terpinol, have detectable free radical
scavenging, antioxidant, and anti-inflammatory
properties (10). Regarding the effect of this plant on
the hypothalamic-pituitary axis and to determine
its effect on PCOS for the first time, we decided
to evaluate the effect of the extract of this seed
on the histological and hormonal levels and the
appropriate dosage of the extract to reduce
ovarian cysts, insulin resistance, and oxidative
stress in rats model of the PCOS.
2. Materials and Methods
2.1. Animals
In this experimental study, which was carried
out in 2017 at the Qom University of Medical
Sciences, 36 female Wistar rats (60 ± 10 gr, aged
21 days) (11) obtained from the animal house of the
Qom Medical University were used. The rats were
housed in a room with controlled temperature (23
± 2°C) and luminosity (12-hr light/dark cycles) with
free access to food and water.
2.2. Experimental groups
Rats were randomly divided into six groups (n =
6/each):
Group 1 (control): rats received no medication;
Group 2 (PCOS): dehydroepiandrosterone
(DHEA)-induced PCOS-control or PCOS;
Group 3 (PCOS+ Met) as a positive control: rats
with PCOS receiving 30 mg/100 g of Metformin
(Chemidarou Co. Tehran, Iran) through gavage for
one month;
Groups 4 (PCOS + N.S 50), Groups 5 (PCOS +
N.S 100) and Groups 6 (PCOS + N.S 200): PCOS
rats which received a hydroalcoholic extract of N.
Sativa seeds in doses of 50, 100, and 200 mg/kg
respectively, through gavage for one month.
2.3. Plant preparation and extract
The seeds of N. sativa were purchased from
a local market in Qom (Iran) and authenticated
scientifically by the Department of Medicinal
Plants, QomUniversity ofMedical Science (voucher
specimen: PMP-735). The maceration method was
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used for the preparation of the extract. To prepare
the hydroalcoholic extract, 50 gr of seed powder
was soaked in 200 ml of hydroalcoholic solvent
(distilled water-ethanol 96% mixture; 60-40) and
kept for 72 hr in a closed container at room
temperature. Then, the contents of the container
were filtered using a Buchner funnel (Whatman’s
filter paper, No. 1), after removing the solvent and
drying at room temperature, to obtain the semisolid
mass which was kept at 4°C prior to use (12,
13).
2.4. Induction of PCOS model
PCOS was induced by a subcutaneous injection
of DHEA (60 mg/kg, Cayman, USA) dissolved in
sesame oil for 3 wk. According to other similar
studies on PCOS induction, after 21 days of DHEA
injection, the rats were subjected to vaginal smear
tests to determine the irregularity of the estrous
cycle and the occurrence of persistent vaginal
carnification (PVC), which is one of the symptoms
of follicular cysts in the ovary (14). Moreover, the
induction of PCOS was confirmed by serological
tests (such as increase in LH, testosterone,
and HOMA-IR levels and decrease in FSH and
progesterone levels) and histomorphometric
studies (wherein one or both ovaries can contain
multiple small, immature ovarian follicles as
cysts).
2.5. Serum analysis
At the end of the treatment period and 24 hr
after the last gavage, the animals were subjected to
deep anesthesia with diethyl ether. Blood samples
were directly collected by cardiac puncture and
centrifuged (Eppendorf centrifuge 5702, Germany)
at 3,000 rpm for 15 min to separate serum samples
(Eppendorf centrifuge 5702, Germany) (15, 16).
Serum levels of FSH, LH, progesterone, estradiol,
and testosterone were measured by the ELISA kit
(Pars Azmoon, Iran) according to themanufacturer’s
kit.
Moreover, while the fasting blood glucose (FBG)
was determined through a lateral tail vein using
an Elegance glucometer (CT-X10, Convergent
Technologies, Germany) and serum insulin levels
were also measured using commercial ELISA kit
(Monobimd, California, USA).
Furthermore, the indices of insulin resistance
at the beginning and end of the treatment using
HOMA-IR (Homeostasis Model Assessment of
Insulin Resistance) were calculated according to
the following equation: fasting glucose (mg/dl) ×
fasting insulin (µIU/ml)/405 (17).
2.6. Antioxidant assessment
Serum antioxidant enzyme superoxide
dismutase (SOD) (ZB-SOD-96A), glutathione
peroxidase (GPX) (ZB-GPX-96A) (18), and catalase
(CAT) (ZB-CAT-96A) activities were measured
using ELISA assays kits (ZellBio GmbH, Germany),
according to the provider’s instructions.
Also, malondialdehyde (MDA) level as a
biomarker of lipid peroxidation was assayed
according of the kit protocol (ZB-MDA-96A).
2.7. Ovarian morphology
After the blood collection, uterus and ovaries
were removed from the body of the rats for
histopathological study.
After removing the adherent connective adipose
tissue, then the ovaries tissues were embedded
in a solution containing 10% formaldehyde for
at least 48 hr for fixation. Afterwards, the tissue
preparation phase were carried out according
to the standard protocols. The samples were
dehydrated, embedded in paraffin, serially
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sectioned, and stained with hematoxylin and
eosin. Follicles were counted in all section and
classified according to the study of Luo and
collaborators (19).
2.8. Ethical considerations
Procedures related to the animals were
approved by the Ethical Committee of
Qom University of Medical Sciences (code:
IR.MUQ.REC.1394.119) and the Ethical Principles of
work on animals were taken in accordance with
the agenda of the Ethics Committee of the Medical
Sciences University.
2.9. Statistical analysis
Data were indicated as mean ± SEM. Statistical
evaluation was done by analysis of variance (one-
way ANOVA), followed by Tukey’s test. The test
was performed using the SPSS Statistics, v. 17.01
(Statistical Package for the Social Sciences, SPSS
Inc., Chicago, USA). P < 0.05 was considered
statistically significant.
3. Results
3.1. Effect of hydroalcoholic extract of
N. sativa seed on hormonal levels
3.1.1. Serum LH and FSH levels
The results of this study showed that LH level
increased in PCOSgroup (p<0.001). The treatment
of PCO animals with metformin and doses of
50, 100, and 200 mg/kg of the N. sativa extract
decreased LH levels (p < 0.001 and p = 0.05
respectively). The level of FSH decreased in PCOS
rats, while it and FSH increased in other groups
(Table I).
3.1.2. Serum testosterone level
The testosterone levels elevated in PCOS rats (p
< 0.001) and treatment with metformin and a dose
of 200 mg/kg N. sativa reduced it (p = 0.003 and
p = 0.01, respectively) (Table I).
3.1.3. Serum progesterone and estrogen
levels
The mean serum level of progesterone
downregulated in the PCOS group (p = 0.01).
Receiving a dose of 200 mg/kg of N. sativa extract
increased the progesterone level (p = 0.03). Data
of the present study showed that the level of
estrogen upregulated in the PCOS group while it
decreased in all treatment groups (Table I).
3.1.4. Glucose, insulin levels, and HOMA-
IR
Following the induction of PCOS, the insulin and
FBG levels increased (p = 0.001). The treatment of
PCO rats with metformin and a dose of 200 mg/kg
of N. sativa extract decreased the FBG levels (p
= 0.03), while the doses of 100 and 200 mg/kg (p
= 0.03 and p = 0.002, respectively) decreased the
insulin level. In addition, the treatment of PCO rats
with metformin and doses of 100 and 200 mg /kg
(p = 0.01, p = 0.02 and, p < 0.001, respectively) of
the extract reduced the insulin resistance (Table II).
3.2. Effect of hydroalcoholic extract
of N. sativa seed on oxidative stress
markers
The induction of PCOS decreased the levels of
SOD, GPX and CAT (p < 0.001) and increased the
level of MDA (p < 0.001) in rat’s serum. Treating
the PCOS rats with a dose of 200 mg/kg of the N.
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sativa extract increased the SOD (p = 0.003), GPX
(p = 0.002), and CAT (p = 0.02) levels. Also, a dose
of 100mg/kg of the extract increased the GPX level
(p = 0.02). In addition, receiving the extract in doses
100 (p = 0.006) and 200 mg/kg (p < 0.001) in the
PCOS groups decreased MDA levels. Moreover,
the administration of metformin in the PCOS group
increased the level of SOD (p = 0.01) and CAT (p =
0.12) (Table III).
3.3. Effect of hydroalcoholic extract of
N. sativa seed on body weight
After 4 wk, the final body weight of PCOS rats
increased in the PCOS group compared to the
intact control group. Despite the decreased body
weight in other groups, there were no significant
differences in this item (Figure 1).
3.4. Results of histopathological study
The normal histological view of the ovary
was observed in the control group (Figure 2).
The histopathological evaluation of ovarian
tissues showed damaging changes in PCOS rats.
A slight decrease was observed in the mean
number of primordial and primary follicles of
the PCOS group in comparison to the control
group. The mean number of secondary and
graffian follicles were decreased in the PCOS
rats (p ≤ 0.001). However, a clear increase in
cystic (p ≤ 0.001) and atretic follicles and a
decrease in corpus luteum (p ≤ 0.001) was
perceived in the PCOS-induced rats. Treatment
with metformin and N. sativa seed extract, to
some extent, improved the pathological changes.
A dose of 200 mg/kg of the extract reversed
these changes related to primary follicles (p
≤ 0.001). While administration 200 mg/kg of
the extract increased the number of graafian
follicles (p ≤ 0.001) it decreased the number
of cystic follicles (p = 0.01). Receiving dose of
100 mg/kg of extract decreased the atretic
follicles (p ≤ 0.001). Moreover administration
of doses of 50, 200 mg/kg of extract and
also receiving metformin reduced the atretic
follicles in comparison to PCO group (p =
0.03, p = 0.04 and p = 0.02, respectively).
Also, the doses of 50 and 100 mg/kg of
the extract increased the corpus luteum (p
≤ 0.001 and p ≤ 0.001, respectively). Table
IV presents the number of different ovarian
follicles.
Table I. Effect of hydroalcoholic extract of N. sativa seed on FSH, LH, testosterone, progesterone and estradiol levels in
dehydroepiandrosterone-induced PCOS rats
Groups
Factors FSH (mIU/mL) LH (mIU/mL) Estradiol (pg/mL) Testosterone (ng/ml) Progesterone (ng/ml)
Control 15.62 ± 0.68 18.28 ± 0.31*** 20.02 ± 2.84 41.01 ± 4.11*** 38.40 ± 3.82*
PCOS 13.45 ± 0.41 27.76 ± 0.83### 32.96 ± 3.72 87.22 ± 6.61### 20.16 ± 2.08#
PCOS + Met 14.49 ± 0.58 23 ± 0.94#** 26.36 ± 3.45 55.92 ± 4.26 32.34 ± 4.31
PCOS + NS 50 13.70 ± 0.41 24 ± 1.3#* 29.24 ± 2.66 76.40 ± 4.86## 25.92 ± 2.45
PCOS + NS 100 14.01 ± 0.45 19.80 ± 0.94** 32.70 ± 2.59 68.10 ± 5.94# 29.52 ± 3.61
PCOS + NS 200 14.42 ± 0.66 17.30 ± 0.63 ** 24.02 ± 2.45 60.17 ± 3.98* 36.54 ± 0.40*
Data are indicated as Mean ± SEM. Statistical evaluation was done by analysis of variance (one-way ANOVA), followed by
Tukey’s test. A value of ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.00 was considered as significant versus the PCOS control group, A
value of #p < 0.05, ##p < 0.01, and ###p < 0.00 was considered as significant versus the intact control group, PCOS: Polycystic
ovarian syndrome, Met: Metformin, NS: Nigella sativa seed, FSH: Follicle-stimulating hormone, LH: Luteinizing hormone
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Table II. Effect of hydroalcoholic extract of N. sativa seed on insulin, glucose, and HOMA-IR levels in dehydroepiandrosterone-
induced PCOS rats
Groups
Factors FBG (mg/dl) Insulin (μIU/ml) HOMA-IR
Control 93 ± 7.04*** 2.95 ± 0.34*** 0.66 ± 0.07***
PCOS 187.6 ± 12.89### 5.97 ± 0.51### 2.73 ± 0.20###
PCOS + Met 128.6 ± 14.74* 4.46 ± 0.51 1.53 ± 0.24*
PCOS + NS 50 147.6 ± 13.88 4.74 ± 0.52 1.77 ± 0.34#
PCOS + NS 100 160.6 ± 14.03# 3.91 ± 0.48* 1.58 ± 0.28*
PCOS + NS 200 128.2 ± 12.62* 3.05 ± 0.27** 0.98 ± 0.14***
Data are indicated asMean± SEM. Statistical evaluationwas done by analysis of variance (one-wayANOVA) followed by Tukey’s
test. A value of ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.00 was considered as significant versus the PCOS control group; A value of
#p < 0.05, ##p < 0.01, and ###p < 0.00 was considered as significant versus the intact control group, PCOS: Polycystic ovarian
syndrome, Met: Metformin, NS: Nigella sativa seed, FBG: Fasting blood glucose: HOMA-IR: Homeostatic model assessment of
insulin resistance
Table III. Effect of hydroalcoholic extract of N. sativa seed onmalondialdehyde and antioxidant levels in dehydroepiandrosterone-
induced PCOS rats
Groups
Factors SOD activity (U/mg protein) GPX (U/mg protein) CAT activity (U/mg protein) MDA (nmol/mg protein)
Control 76 ± 6.72*** 102.60 ± 7.15*** 127.80 ± 9.31*** 34.20 ± 3.05***
PCOS 33.40 ± 3.74### 42.60 ± 4.23### 73 ± 5.76### 76 ± 5.70###
PCOS + Met 58.40 ± 5.25* 64.60 ± 5.59### 113.20 ± 10.09* 59.60 ± 5.17#
PCOS + NS 50 35.80 ± 3.02### 50.60 ± 4.01### 87.80 ± 5.23# 65.60 ± 4.52##
PCOS + NS 100 53 ± 4.93# 68.60 ± 5.10##* 94.40 ± 5.87 48.40 ± 6.40**
PCOS + NS 200 63.60 ± 5.22** 77.40 ± 5.58#** 111 ± 8.21* 39.80 ± 3.38***
Data are indicated as Mean ± SEM. Statistical evaluation was done by analysis of variance (one-way ANOVA), followed by
Tukey’s test. A value of *p < 0.05, **p < 0.01, and ***p < 0.001 was considered as significant versus the PCOS control group;
A value of #p < 0.05, ##p < 0.01, and ###p < 0.001 was considered as significant versus the intact control group, PCOS:
Polycystic ovarian syndrome, Met: Metformin, NS: Nigella sativa seed, MDA: Malondialdehyde, SOD: Superoxide dismutase,
GPX: Glutathione peroxidase, CAT: Catalase
Table IV. Number of primordial, primary, secondary, graafian and atretic follicles, corpus luteum, and cyst in the ovarian tissues in
















Control 55.0 ± 1.51 28.0 ± 0.94 21.0 ± 0.82 7.2 ± 0.24 3.3 ± 0.12 5.7 ± 0.29 0.0 ± 0.0
PCOS 50.0 ± 1.47 24.0 ± 0.94 17.0 ± 0.61### 5.0 ± 0.20### 2.5 ± 0.12## 7.0 ± 0.33 9.0 ± 0.24###
PCOS + Met 50.0 ± 1.51 27.0 ± 0.94 19.0 ± 0.57 5.8 ± 0.57# 2.7 ± 0.08# 5.5 ± 0.24∗ 8.5 ± 0.37###
PCOS + NS 50 51.0 ± 1.51 25.0 ± 0.98 17.0 ± 0.57### 5.2 ± 0.57### 3.6 ± 0.16∗∗∗ 5.5 ± 0.29∗ 8.5 ± 0.29###
PCOS + NS 100 52.0 ± 1.39 23.0 ± 0.86## 15.0 ± 0.53### 5.1 ± 0.57### 3.2 ± 0.12∗∗ 5.2 ± 0.33∗∗ 8.7 ± 0.29###
PCOS + NS 200 53.1 ± 1.39 29.0 ± 0.94∗∗ 19.0 ± 0.53 7.0 ± 0.24∗∗∗ 3.0 ± 0.12 5.5 ± 0.37∗ 6.0 ± 0.29###∗∗
Data are indicated as Mean ± SEM. Statistical evaluation was done by analysis of variance (one-way ANOVA), followed by
Tukey’s test. A value of ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.00 was considered as significant versus the PCOS control group;
A value of #p < 0.05, ##p < 0.01, and ###p < 0.00 was considered significant versus the intact control group, PCOS: Polycystic
ovarian syndrome, Met: Metformin, NS: Nigella sativa seed
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Figure 1. Effect of hydroalcoholic extract of N. sativa seed extract on body weight after four weeks in the dehydroepiandrosterone-
induced PCOS rats. Results are expressed as Mean ± SEM. CON: Control, PCOS: Polycystic ovarian syndrome, MET: Metformin,
N.S: N. sativa seed extract.
Figure 2. Light microscopy of ovarian tissue samples stained using hematoxylin and eosin. The morphology of follicles in the
control (A), PCOS-induced rats (B), 300 mg/kg metformin-treated (C), 50 mg/kg black seed (N. sativa)-treated (D), 100 mg/kg
black seed (N. sativa)-treated (E), and 200 mg/kg black seed (N. sativa)-treated (F) groups are shown. Cells were stained with
hematoxylin and eosin. PF: Primordial follicle, PRF: Primary follicle, GF: Graafian follicle, AF: Atretic follicle, NO: Normal oocyte,
DGr: Degenerated granulosa cells (H&E, 10x).
4. Discussion
In women with PCOS, the serum levels of
testosterone, estradiol, and LH are increased and
FSH and progesterone levels are decreased (17).
In this study, the treatment of rats with DHEA
elevated the LH, estrogen, and testosterone levels,
and decreased the FSH and progesterone levels,
which is consistent with the results of Walters
study Walters study following the same model of
inducing PCOS (20). Therefore, it seems that the
factors which can lower LH and estrogen levels and
increase the level of FSH and progesterone can be
used to treat this disease.
The N. sativa seed, which is a plant about which
the Prophet Muhammad (peace and blessings be
upon him) said, “There is healing in the black
seed for all diseases except death,” was used in
this study (21). In this study, the administration of
N. sativa extract decreased the estrogen levels
in the PCOS rats. Phytoestrogens are the active
compounds of this extract which are able to,
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directly and indirectly, attach to estrogen receptors
and cause significant estrogen-like effects (22).
This effect, by negative feedback, reduces the
plasma levels of estrogen. Also, the administration
of the extract decreased the LH levels in PCOS
rats. According to research, this may be related
to linoleic acid (CLA) in N. sativa, which has a
decreasing effect on LH levels. This effect of CLA
is through the inhibition of nitric oxide and leptin,
which are important controllers for the release of
LH (23).
In DHEA-induced PCOS model, the co-
occurrence of hyperandrogenism and decrease
in FSH level, observed in our study, is very
common. We believe that it can be claimed that the
hydroalcoholic extract of N. sativa seed showed
remarkable antiandrogenic effects by reducing
elevated testosterone levels. This property of
the extract is possibly due to the presence of
phytoestrogens in the extract. More studies
are required to elucidate the exact functional
mechanism of the extract. Furthermore, increasing
the level of androgens can increase the level of
FSH receptors in PCOS patients (24), thus lowering
the FSH serum level by negative feedback.
Previous studies in PCOS indicate the relationship
between the increased levels of LH or decreased
FSH levels and creating insulin resistance.
Disruption in the usual hypothalamic-pituitary-
gonadal axis increases both the levels of
testosterone and LH leading to the disease
state (24). LH stimulates testosterone secretion
from ovarian theca cells through the PI3K/Akt
pathway further elevating the activity of 17-
a hydroxylase enzyme which catalyzes the
conversion of progesterone to androgens,
culminates in diminishing the progesterone level,
and elevates the androgens level (25). Thus, the
anti-androgenic effects of N. sativa seed may be
due to its potentials obstructing the PK13 pathway.
The results of the tests showed that the level of
glucose, insulin, and insulin resistance significantly
increased in the PCOS rats compared to the
healthy control group. Reduction in serum glucose
observed in the PCOS rats treated with N. sativa
can occur for various reasons. Thymoquinone
in N. sativa seed can reduce the expression of
gluconeogenic enzymes and the production of
hepatic glucose (26).
In addition, it has been shown that the liquid
intake of N. sativa seed extract reduces glucose
absorption and inhibits glucose carriers in diabetic
rats (27). Our results verify the positive and
dose-dependent effect of N. sativa seed in
improving insulin resistance and serum level
changes of insulin in PCOS rats. The findings
suggests that hyperinsulinemia may enhance
the chemerin gene expression in polycystic
ovaries in which chemerin may play a role in
pathophysiology of PCOS by direct action on ovary
(28).
In addition, the mechanism responsible for
insulin resistance is obscure. Insulin resistance is
worsened by extreme fatmass or unusual secretion
or function of adipocytokines such as chemerin
(29). Furthermore, according to our results, in a
human study it was shown that receiving N. sativa
caused a decrease in the insulin resistance (26). In
our study, the induction of PCOS led to a decrease
in progesterone levels. This may be due to the
expression of the chemerin gene which inhibited
FSH-induced progesterone secretion in granulosa
cells by prevention of aromatase and p450scc
expression (30). The results of this study showed
that as expected, metformin as standard drug
for PCOS treatment could significantly decrease
testosterone, LH, insulin resistance, and glucose
serum level compared to the PCOS-induced
groups. However, it seems that one of the
mechanisms involved in the function of metformin
in the treatment of PCOS is its effect on reducing
the gene expression of chemerin, which has been
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reported in various studies (31). In our study, the
weight of PCOS rats increased, and treatment
with N. sativa caused a drop in weight. In a
human study, similar to our research, two months
of N. sativa administration to menopausal women
led to weight loss compared to the PCOS group
(32). study has indicated the anti-obesity results
of Nigella, due to its affirmative effects against
insulin sensitivity and its immune-modular effects
(33).
In addition, N. sativa might possess anorectic
effects and can cause a decrease in food
intake. Despite these dates, more controlled
intervention researches are necessary for higher
comprehension the effects of N. sativa on
weight loss. The increased androgens and insulin
resistance can lead to oxidative stress (34), and
the role of oxidative stress in PCOS pathogenesis
can never be neglected (35). Therefore, reducing
oxidative stress by increasing the activity of
antioxidant enzymes can be one of the effective
therapies in these patients. The results of
this study showed that antioxidant enzymes
levels increased and the malondialdehyde level
decreased in rat’s model of PCOS after treatment
with the extract of N. sativa seed. This result is
similar to the results of Leong and colleagues
(36).
Recent studies have shown that thymoquinone
in black seeds have inhibitory effects on
free radicals (37, 38) and the potential
antihyperglycemic properties of N. Sativa is
based on its antioxidant content. Moreover,
N. sativa is reported to stimulate paraoxonase
enzyme, which functions as an antioxidant (27).
Furthermore, flavonoids, active ingredients in
N. sativa seed (21), have antioxidant properties
(39). The results of hormonal analysis were
also supported by histopathological findings
of the uterus as histopathological changes
reached up in the PCOS group relative to the
control group. In PCOS rats follicular atresia
increased.
Corpus luteum is a necessary factor for the
synthesis of progesterone which affects the
reproductive cycles and supports the uterus
for implantation if conception happen, as in
this study, in the PCOS group, the Corpus
luteum was decreased accompanied by decline
in progesterone level (40). Decrement in
secondary follicles number because of the
overproduction of androgens prevents normal
follicular maturation process in PCOS group.
However, the extract and metformin groups
indicated a remarkable improvement of ovarian
tissue with the appearance of reduction in
cysts and outstanding regular luteinization
(35).
5. Conclusion
The results of this study suggest that N.
sativa seed extract has hypoglycemic, antioxidant
effect and can modulate hormones related to
fertility in PCOS rats. However, its use in the
long-term treatment of PCOS, requires more
investigation.
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